Loading insider details...
Beta
Latest Form 4 (Oct 1, 2026): Exercise/Conversion of 7,500 MAZE shares, $78.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |
| Sep 4, 2026 | Maze Therapeutics, Inc. (MAZE) | Sale | 2,800 | $73.9K |
| Sep 3, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 12,500 | n/a |
| Aug 31, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |
| Jul 31, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |
| Jul 1, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |
| Jun 2, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |
| May 6, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 8,320 | $86.7K |
| May 1, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |
| Apr 1, 2026 | Maze Therapeutics, Inc. (MAZE) | Exercise/Conversion | 7,500 | $78.2K |